Journey with AxxessBio:
Stay informed with our latest news, press releases and shared milestones

Latest News and Releases

AxxessBio announces an exclusive distribution agreement with ADIENNE for TEPADINA® (Thiotepa)

June 2020, AxxessBio announces an exclusive distribution agreement with ADIENNE (Lugano – Switzerland) for TEPADINA® (Thiotepa) for Singapore, Thailand, Malaysia, Vietnam, Philippines and Brunei. TEPADINA® 15mg and 100mg powder for concentrate for solution for infusion is used in combination with other chemotherapy medicinal products, as conditioning treatment prior to allogeneic or autologous hematopoietic

Read More »

Early Access Programs collaboration with myTomorrows

February 2018, a collaboration agreement was signed between AxxessBio and myTomorrows  to create awareness on the availability of non-registered products in Asia under the Early Access Programs, e.g., Named Patient Importation, as per local regulations, and for myTomorrows’s search engine for unregistered medicinal products.   The partnership between AxxessBio and

Read More »

Interested in Partnering Up?

At AxxessBio, we are continuously looking for partnerships to bring new innovative therapies for patients all around Asia